Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Effect of TMS Treatment on Defense Mechanisms and Functionality in Patients With Depression

NCT: NCT07853989 · NOT_YET_RECRUITING

NCT IDNCT07853989
StatusNOT_YET_RECRUITING
Start Date2026-10-01
Completion2027-07-01
SponsorNamik Kemal University (OTHER)
First posted
Last updated

Brief Summary

This prospective observational study aims to evaluate changes in psychological defense mechanisms in patients with non-psychotic major depressive disorder (MDD) undergoing repetitive Transcranial Magnetic Stimulation (rTMS) therapy. The study investigates whether rTMS induces a shift from immature to more mature defense mechanisms and assesses how these changes relate to improvements in depressive symptom severity, anxiety levels, and overall functionality at baseline, 1-month, and 3-month follow-ups.

Frequently Asked Questions

What is Effect of TMS Treatment on Defense Mechanisms and Functionality in Patients With Depression?

Effect of TMS Treatment on Defense Mechanisms and Functionality in Patients With Depression is a clinical trial registered under NCT07853989. Current status: NOT_YET_RECRUITING.

What is the status of NCT07853989?

The current status of NCT07853989 (Effect of TMS Treatment on Defense Mechanisms and Functionality in Patients With Depression) is: NOT_YET_RECRUITING.

When did Effect of TMS Treatment on Defense Mechanisms and Functionality in Patients With Depression start?

Effect of TMS Treatment on Defense Mechanisms and Functionality in Patients With Depression started on 2026-10-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑